Policy & Regulation
20 November 2018 - BioPharma Services Inc (BioPharma) revealed on Monday that it has successful passed World Health Organization (WHO) GCP/GLP/BE assessment and review of its Toronto, Canada site.The ...
20 November 2018 - Genmab A/S (CPH:GEN), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Monday t...
20 November 2018 - Roivant Sciences, a company that in-licenses late-stage drug candidates and develops them through subsidiaries, has signed a global licensing agreement with Korea-based iNtRON Biote...
20 November 2018 - Anglo–Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca's Imfinzi (durvalumab) monotherapy and the combination of Imfinzi with remelimumab ha...
20 November 2018 - The US Food and Drug Administration (FDA) has approved the expansion of the label for Switzerland-based Novartis' Promacta (eltrombopag) to include first-line treatment for adu...
20 November 2018 - - The Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending approval of the Opdivo (nivolumab) plus low-d...
Related Headlines